BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 10634386)

  • 1. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
    Colao A; Baldelli R; Marzullo P; Ferretti E; Ferone D; Gargiulo P; Petretta M; Tamburrano G; Lombardi G; Liuzzi A
    J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
    Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.
    Colao A; Pivonello R; Grasso LF; Auriemma RS; Galdiero M; Savastano S; Lombardi G
    Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?
    López-Velasco R; Escobar-Morreale HF; Vega B; Villa E; Sancho JM; Moya-Mur JL; García-Robles R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1047-53. PubMed ID: 9100571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
    Pivonello R; Galderisi M; Auriemma RS; De Martino MC; Galdiero M; Ciccarelli A; D'Errico A; Kourides I; Burman P; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):476-82. PubMed ID: 17105844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of somatostatin analogues on acromegalic cardiomyopathy: results from a prospective study using cardiac magnetic resonance.
    Bogazzi F; Lombardi M; Strata E; Aquaro G; Lombardi M; Urbani C; Di Bello V; Cosci C; Sardella C; Talini E; Martino E
    J Endocrinol Invest; 2010 Feb; 33(2):103-8. PubMed ID: 20348836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
    Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
    Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiological findings in acromegaly].
    Ferramosca B; Bianchi D; Serra D; Savini R; Villecco AS; Bugiardini R
    Minerva Med; 1987 Dec; 78(24):1813-21. PubMed ID: 3431727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics.
    Minniti G; Jaffrain-Rea ML; Moroni C; Baldelli R; Ferretti E; Cassone R; Gulino A; Tamburrano G
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):101-6. PubMed ID: 9797853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging.
    Bogazzi F; Lombardi M; Strata E; Aquaro G; Di Bello V; Cosci C; Sardella C; Talini E; Martino E
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):361-8. PubMed ID: 17854389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O; Beauregard C; Hardy J
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.